How is the Oncocyte Corporation today?

The Oncocyte Corporation today is trading in the green, up by 1.84% at 3.32.

What is Oncocyte Corporation Annual Revenue?

Oncocyte Corporation Annual Revenue rose 25.15%, in the last year to $1.88 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Oncocyte Corporation Annual Net Profit?

Oncocyte Corporation Annual Net Profit fell 118.36% in the last year to $60.66 M. Its sector's average net profit growth for the last fiscal year was -11.09%.

What is Oncocyte Corporation Price to Earning Ratio?

Oncocyte Corporation Price to Earning Ratio is -1.63, which is negative.

What is Oncocyte Corporation Stock Price?

Oncocyte Corporation Stock Price rose 25.28% and underperformed its sector by 30.19% in the past year.

What is Oncocyte Corporation Quarterly Revenue?

Oncocyte Corporation Quarterly Revenue rose 1,114.77% YoY to $2.14 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Oncocyte Corporation Quarterly Net profit?

Oncocyte Corporation Quarterly Net profit rose 26.93% YoY to $6.67 M. Its sector's average net profit growth YoY for the quarter was -212.88%.

What is Oncocyte Corporation Return on Equity(ROE)?

Oncocyte Corporation Return on Equity(ROE) for the last financial year was -1,487.09%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Oncocyte Corporation Mutual Fund Holding?

Oncocyte Corporation Mutual Fund Holding increased by 0.34% in the last quarter to 3.34.

What is Oncocyte Corporation Promoter Share Holding?

Oncocyte Corporation Promoter Share Holding increased by 0.16% in the most recent quarter to 0.57%.

What is Oncocyte Corporation Interest Coverage Ratio?

Oncocyte Corporation Interest Coverage Ratio is -721.18, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Oncocyte Corporation Institutional Holding?

Oncocyte Corporation Institutional Holding increased by 26.47% in the last quarter to 55.9.

Oncocyte Corporation XNAS: OCX

Oncocyte Corporation Live Share Price Today, Share Analysis and Chart

Name: Oncocyte Corporation: Is Infosys Ltd. worth buying?
Item: Oncocyte Corporation
Rating: 1.78941675
Author: Trendlyne DVM scores

about

OncoCyte Corp is a pioneering diagnostics technology company. Its mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The company develops diagnostic tests based on liquid biopsies using blood or urine ...

3.32 0.06 (1.84%)

30.11% Fall from 52W High

14,324 XNAS Volume

XNAS 30 May, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

4.2 / 100

Technically Moderately Bullish

67.4 / 100

5

1Yr Price target upside is 63%

3 analysts

Oncocyte Corporation Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Oncocyte Corporation FAQ

How is Oncocyte Corporation today?

Oncocyte Corporation today is trading in the green, and is up by 1.84% at 3.32.

How has Oncocyte Corporation performed historically?

Oncocyte Corporation is currently trading up 1.84% on an intraday basis. In the past week the stock fell -1.48%. stock has been up 29.18% in the past quarter and rose 25.28% in the past year. You can view this in the overview section.